ARTEMETHER 80mg. IP + LUMEFANTRINE 480mg. IP

An antimalarial medication that works together by killing the malaria-causing parasites thereby preventing further spread of the infection. An artemisinin-derived combination antimalarial approved by the Food and Drug Administration in 2009 for the treatment of Plasmodium falciparum malaria. (Kayla R Stover, 2012) The drug of choice for the treatment of uncomplicated falciparum malaria. (Yehenew A. Ebstie, 2015) A highly effective and well-tolerated antimalarial agent with cure rates >95%. (Jay Prakash Jain, 2017) A beneficial drug that has developed resistance to other antimalarial drugs such as chloroquine and sulphadoxine-pyrimethamine. (Jay Prakash Jain, 2017) A fast-acting drug that quickly reduces the parasite biomass and resolves the clinical symptoms. (Praveen K. Bharti, 2016) The most widely used artemisinin-based combination therapy for treating uncomplicated falciparum malaria globally. (Awoke Derbie, 2020) Clears parasitemia more rapidly than amodiaquine-sulfalene-pyrimethamine in uncomplicated Plasmodium falciparum malaria patients. (Akintunde Sowunmi, 2007) The first-line treatment for uncomplicated Plasmodium falciparum malaria or mixed infections (Plasmodium falciparum and Plasmodium vivax). (Gilbert Lefèvre, 2013) A safe and effective treatment for children and adults with Plasmodium falciparum malaria. (Kayla R Stover S. T., 2012) A viable alternative to artesunate plus sulphadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria. (Neena Valecha, 2009)